Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Equities
US8902604094
Pharmaceuticals
Financials (USD)
Sales 2024 * | 16.33M | Sales 2025 * | 18.2M | Capitalization | 17.15M |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -88M | EV / Sales 2024 * | 1.05 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
-0.18
x | P/E ratio 2025 * |
-0.26
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.99% |
1st Jan change | Capi. | |
---|---|---|
-3.45% | 87.17B | |
+2.76% | 40.1B | |
-16.18% | 31.38B | |
+57.86% | 25.12B | |
-16.02% | 15.59B | |
-9.12% | 12B | |
-42.56% | 11.8B | |
-17.94% | 11.8B | |
+6.89% | 8.81B |